Table 1 Characteristics of patients with early rheumatoid arthritis (RA) and healthy controls (HC)
Early RA | HC | |||
|---|---|---|---|---|
Number | 58 | 54 | ||
Sex, female/male, n | 42/16 | 41/13 | ||
Age, years | 54.93 ± 16.18 | 50.87 ± 15.11 | ||
Disease duration | <6 months | |||
Treatment after 3 months | ||||
Glucocorticoids | 46 | |||
Methotrexate | 49 | |||
Leflunomide | 1 | |||
Sulfasalazine | 4 | |||
Hydroxychloroquine | 2 | |||
Clinical characteristic | Baseline | 3 months | 6 months | |
RF IgM positivity, % | 52 | NA | NA | NA |
Anti-CCP positivity, % | 66 | NA | NA | NA |
DAS28 | 5.56 ± 1.56 | 3.05 ± 1.42 | 2.86 ± 1.25 | NA |
CRP, mg/l | 9.16 (0.30, 152.20) | 3.10 (0.21, 23.85) | 2.83 (0.24, 44.44) | 1.02 (0.22, 4.36) |
ESR, mm/h | 27.00 (4.00, 107.00) | 15.50 (2.00, 54.00) | 14.00 (2.00, 74.00) | NA |